- $1.13bn
- $3.05bn
- $3.26bn
- 84
- 97
- 65
- 96
Annual balance sheet for Adapthealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K/A | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 100 | 150 | 46.3 | 77.1 | 110 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 171 | 360 | 359 | 389 | 408 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 363 | 670 | 585 | 649 | 756 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 110 | 546 | 622 | 638 | 618 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 1,813 | 5,250 | 5,220 | 4,509 | 4,487 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 422 | 500 | 456 | 537 | 567 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,459 | 3,189 | 3,068 | 3,050 | 2,916 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 355 | 2,062 | 2,151 | 1,458 | 1,571 |
Total Liabilities & Shareholders' Equity | 1,813 | 5,250 | 5,220 | 4,509 | 4,487 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |